≡

Granzyme B (GZMB)

[Edit]

GZM-B; HLP; CTLA1; CCPI; CGL1; CSP-B; CSPB; CTSGL1; SECT; Granzyme 2; Cytotoxic T-Lymphocyte-Associated Serine Esterase 1; Fragmentin 2; Cytotoxic Serine Protease B

Granzyme B (GZMB)
CCC A600
HGNC 4709
MGI 109267
PubMed 12752668
RGD 620018
UniProt P10144
Wiki Granzyme_B

Granzymes are serine proteases that are released by cytoplasmic granules within cytotoxic T cells and natural killer cells. Granzyme B is an important mediator of cytotoxic lymphocyte granule-induced death of target cells, accomplishing this through cleavage of Bid and cleavage and activation of caspases as well as direct cleavage of downstream substrates.

The serine proteinase GZMB is crucial for the rapid induction of target cell apoptosis by cytotoxic T cells. GZMB enters cells in a perforin-independent manner, predicting the existence of a cell surface receptor(s). Motyka et al. (2000) presented evidence that this receptor is the cation-independent mannose 6-phosphate receptor (CIMPR), also called IGF2R. Inhibition of the GZMB-IGF2R interaction prevented GZMB cell surface binding, uptake, and the induction of apoptosis.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA600Hu01 Recombinant Granzyme B (GZMB) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA600Hu01 Polyclonal Antibody to Granzyme B (GZMB) WB; IHC
MAA600Hu22 Monoclonal Antibody to Granzyme B (GZMB) WB
MAA600Hu21 Monoclonal Antibody to Granzyme B (GZMB) WB
Assay Kits SEA600Hu ELISA Kit for Granzyme B (GZMB) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA600Mu01 Recombinant Granzyme B (GZMB) Positive Control; Immunogen; SDS-PAGE; WB.
RPA600Mu02 Recombinant Granzyme B (GZMB) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA600Mu01 Polyclonal Antibody to Granzyme B (GZMB) WB; IHC; ICC; IP.
PAA600Mu02 Polyclonal Antibody to Granzyme B (GZMB) WB; IHC; ICC; IP.
Assay Kits SEA600Mu ELISA Kit for Granzyme B (GZMB) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA600Ra01 Recombinant Granzyme B (GZMB) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA600Ra01 Polyclonal Antibody to Granzyme B (GZMB) WB; IHC; ICC; IP.
MAA600Ra21 Monoclonal Antibody to Granzyme B (GZMB) WB; IHC; ICC; IP.
Assay Kits SEA600Ra ELISA Kit for Granzyme B (GZMB) Enzyme-linked immunosorbent assay for Antigen Detection.
  1. "Induction of mRNA for a serine protease and a beta-thromboglobulin-like protein in mitogen-stimulated human leukocytes."J. Immunol. 139:250-256(1987) [PubMed] [Europe PMC] [Abstract]
  2. "Structure and differential mechanisms of regulation of expression of a serine esterase gene in activated human T lymphocytes."J. Biol. Chem. 263:6363-6369(1988) [PubMed] [Europe PMC] [Abstract]
  3. "Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes."Proc. Natl. Acad. Sci. U.S.A. 85:6924-6928(1988) [PubMed] [Europe PMC] [Abstract]
  4. "Genomic organization and chromosomal assignment for a serine protease gene (CSPB) expressed by human cytotoxic lymphocytes."Genomics 5:110-117(1989) [PubMed] [Europe PMC] [Abstract]
  5. "Nucleotide sequence and genomic organization of a human T lymphocyte serine protease gene."J. Immunol. 145:737-744(1990) [PubMed] [Europe PMC] [Abstract]
  6. "Structural organization of the hCTLA-1 gene encoding human granzyme B."Gene 87:265-271(1990) [PubMed] [Europe PMC] [Abstract]
  7. "The DNA sequence and analysis of human chromosome 14." Nature 421:601-607(2003) [PubMed] [Europe PMC] [Abstract]
  8. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  9. "Isolation of a cDNA clone encoding a novel form of granzyme B from human NK cells and mapping to chromosome 14."Hum. Genet. 84:465-470(1990) [PubMed] [Europe PMC] [Abstract]
  10. "Characterization of three serine esterases isolated from human IL-2 activated killer cells."J. Immunol. 141:3142-3147(1988) [PubMed] [Europe PMC] [Abstract]
  11. "Characterization of granzymes A and B isolated from granules of cloned human cytotoxic T lymphocytes."J. Immunol. 141:3471-3477(1988) [PubMed] [Europe PMC] [Abstract]
  12. "Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes."J. Immunol. 151:7161-7171(1993) [PubMed] [Europe PMC] [Abstract]
  13. "Human cytotoxic lymphocyte granzyme B. Its purification from granules and the characterization of substrate and inhibitor specificity."J. Biol. Chem. 266:98-103(1991) [PubMed] [Europe PMC] [Abstract]
  14. "Signal peptide prediction based on analysis of experimentally verified cleavage sites."Protein Sci. 13:2819-2824(2004) [PubMed] [Europe PMC] [Abstract]
  15. "Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residue."Biol. Chem. 381:1203-1214(2000) [PubMed] [Europe PMC] [Abstract]
  16. "The three-dimensional structure of human granzyme B compared to caspase-3, key mediators of cell death with cleavage specificity for aspartic acid in P1."Chem. Biol. 8:357-368(2001) [PubMed] [Europe PMC] [Abstract]
  17. "Catalog of 680 variations among eight cytochrome p450 (CYP) genes, nine esterase genes, and two other genes in the Japanese population."J. Hum. Genet. 48:249-270(2003) [PubMed] [Europe PMC] [Abstract]